Trials / Completed
CompletedNCT02377895
Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis
A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Allergen BioCube Study Evaluating the Efficacy and Safety of Nasapaque Nasal Solution in a Population of Adult Subjects With Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- 3E Therapeutics Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy and safety study using the Allergen BioCube (ABC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nasapaque Nasal Solution | |
| DRUG | Placebo Saline Nasal Solution |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2015-03-04
- Last updated
- 2017-01-26
Source: ClinicalTrials.gov record NCT02377895. Inclusion in this directory is not an endorsement.